FRIEDMAN BIOVENTURES
Friedman BioVentures is a firm that invests in early-stage companies with promising technologies.
FRIEDMAN BIOVENTURES
Status:
Active
Similar Organizations
Emerging Ventures
Emerging Ventures is a venture capital firm that invests in pre-seed and seed stage companies that create or use emerging technologies.
IBI Tech Fund
IBI Tech Fund is an Israeli fund investing in early-stage outstanding startups.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-09 | PetDx | Friedman BioVentures investment in Series B - PetDx | 62 M USD |
| 2021-03-01 | DTx Pharma | Friedman BioVentures investment in Series B - DTx Pharma | 100 M USD |
| 2020-06-01 | PetDx | Friedman BioVentures investment in Series A - PetDx | 10 M USD |
| 2020-01-06 | DTx Pharma | Friedman BioVentures investment in Series A - DTx Pharma | 10.6 M USD |
| 2019-05-14 | DTx Pharma | Friedman BioVentures investment in Series A - DTx Pharma | 3 M USD |
| 2018-06-28 | MedCrypt | Friedman BioVentures investment in Seed Round - MedCrypt | 1.9 M USD |
More informations about "Friedman BioVentures"
Friedman Bioventures - FLAIA
In conclusion, Friedman Bioventures is a forward-thinking venture capital and private equity firm that is dedicated to advancing the growth of MedTech. By partnering with innovators who are …See details»
Friedman Bioventure Fund: Performance - PitchBook
Friedman Bioventure Fund is a venture capital fund managed by Friedman BioVentures. The fund is located in San Diego, California. The fund will target to invest in pharmaceuticals and …See details»
Friedman BioVentures investment portfolio - PitchBook
Friedman BioVentures's latest investment was on 07-Nov-2024 in TRIO Pharmaceuticals, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. …See details»
Friedman BioVentures - Investments, Portfolio & Company Exits
Friedman BioVentures has made 2 diversity investments. Their most recent diversity investment was on Dec 9, 2021, when PetDx raised. obfuscated. obfuscated. Announced Date . …See details»
Friedman BioVenture - CB Insights
Dec 10, 2021 The company's $10M Series A financing in August 2020 was led by Friedman Bioventure with participation from Petco (Nasdaq:WOOF) and an undisclosed leading pet …See details»
Friedman BioVentures - Contacts, Employees, Board Members, …
Friedman BioVentures has 1 current employee profile, Managing Partner Jeffrey Friedman. Jeffrey Friedman Managing Partner Browse By: Organizations, People, EventsSee details»
Friedman BioVentures - Company Profile and News
Company profile page for Friedman BioVentures including stock price, company news, executives, board members, and contact informationSee details»
Friedman BioVentures - Zefyron Company Profile
Friedman BioVentures is a firm that invests in early-stage companies with promising technologies.See details»
Friedman BioVentures Fund - CB Insights
Dec 2, 2024 About Friedman BioVentures Fund. Friedman BioVentures Fund is a firm that invests in early-stage companies with promising technologies. It was founded in 2012 and is …See details»
EXSIGHT ANNOUNCES DTX INVESTMENT
Feb 25, 2020 EV was first introduced to the DTx CEO, Dr. Arthur Suckow, nearly two years ago by Dr. Jeff Friedman. We have stayed in touch and closely followed the company’s progress. …See details»
Friedman BioVentures - VC Firm Profile - Gaebler.com Venture …
Friedman BioVentures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know. Tech CompanySee details»
Celsense - Board of Directors
Jeffrey S. Friedman, M.D., Ph.D., is the Managing Partner of Friedman Bioventures, a San Diego-based family investment vehicle, and Chair of the Life Science Committee of the San Diego …See details»
Friedman BioVentures - Crunchbase
Friedman BioVentures is a firm that invests in early-stage companies with promising technologies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Friedman BioVentures – Investors Database – Unicorn Nest
Friedman BioVentures. SAVE. Total investments. 8. Average round size. 23M. Portfolio companies. 5. Lead investments. 2. Follow on index. 0.38. Areas of investment Biotechnology …See details»
Jeffrey S. Friedman | Celsense | United States of America
Jeffrey S. Friedman, M.D., Ph.D., is the Managing Partner of Friedman Bioventures, a San Diego-based family investment vehicle, and Chair of the Life Science Committee of the San Diego …See details»
Jeffrey Friedman MD Profile: Contact Information & Network
Jeffrey Friedman MD General Information Biography. Dr. Jeffrey Friedman is the Founder and serves as Managing Partner at Friedman BioVentures. He serves as a Board Member at TRIO …See details»
Trio Pharmaceuticals Raises $2.2 Million Seed
Apr 11, 2023 Trio Pharmaceuticals, Inc. (TRIO) has been bootstrapping the development of its “three arm” approach to treating cancer since its founding – until now. Shiva Bhowmik, Ph.D. …See details»
Canucks determined to sign Rick Tocchet to extension
2 days ago Vancouver Canucks head coach Rick Tocchet stands on the bench behind Pius Suter, from left to right, Dakota Joshua, Brock Boeser and Jake DeBrusk during first period …See details»
Friedman BioVentures - Updates, News, Events, Signals & Triggers
Friedman BioVentures is a firm that invests in early-stage companies with promising technologies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Jeffrey Friedman - COO @ DTx Pharma - Crunchbase Person Profile
Primary Organization . DTx Pharma . Location California, United States, North America; Regions West Coast, Western US; Gender Male; Investor Type Investment Partner LinkedIn View on …See details»